AsCNP Science Award
AsCNP commences its science award since 2019. This award includes two winners, namely from clinical and basic research scholars, to recognize their great achievements in the field of neuropsychopharmacology. This prize consists of a monetary award of $1,000 (USD) and an engraved plaque for each winner, to be presented at the biannual congress meeting (Morning, September 22，2023，Xi‘An)
- The nominator and nominee should be the member of AsCNP.
- Nominator’s letter of recommendation includes a 500-word statement which summarizes the nominee’s current work activity and achievement
- Nominee’s curriculum vitae include a list of publications.
- The application will begin from 21th Apr 2023 to 30th May 2023. The results will be announced on 1st July.
- The application should be sent to AsCNP Central Office (secretariatascnp.org).
Please fax or mail this application to：
c/o A & E Planning Co., Ltd.
E-mail : secretariatascnp.org
Fax : +81-3-3230-2479
|Clinical Science Award
|Division Chief, Division of Community & Rehabilitation Psychiatry, Department of Psychiatry, Taipei Veterans General Hospital
Laboratory Head, Functional Neuroimaging and Brain Stimulation
Lab Director, Precision Depression Intervention Center
Professor, Department of Psychiatry, National Yang-Ming Chiao-Tung University
Professor, Institute of Brain Science, National Yang-Ming Chiao-Tung University
Professor, Institute of Cognitive Neuroscience, National Central University
|Basic Science Award
|Gavin Stewart Dawe
|The Head of the Department of Pharmacology at the Yong Loo Lin School of Medicine,
The Director of the Neuroscience and Metabolic Phenotyping Core at the National University of Singapore
In the science award of AsCNP 2023, there are four applicants for the clinical field and one for the basic research field. After the scoringby the Award Committee, we are pleased to announce that Prof. Cheng-Ta Li has won the Clinical Science Award, and Prof. Gavin Stewart has won the Basic Science Award.
Prof. Cheng-Ta Li is a senior psychiatrist and an outstanding professor at National Yang Ming Chiao Tung University, Taipei, Taiwan. Prof. Li has long been devoted to the field of treatment-resistant depression (TRD) and has published more than 200 SCI papers. He is ranked in the top 1% in the field of TRD with multidisciplinary expertise, according to the results of Expertscape (2011-2021).
Prof. Dawe is the Head of the Department of Pharmacology at the Yong Loo Lin School of Medicine, as well as the Director of the Neuroscience and Metabolic Phenotyping Core at the National University of Singapore. Dr. Dawe has focused on the study of antipsychotics, antidepressants, anxiolytics, and modulators of cognitive function and neuroplasticity. His scientific work in animal models of schizophrenia, depression, anxiety, and dementia is outstanding and has consistently contributed to significant advancements in the field.
Our President, Tianmei Si, will invite them to give a special lecture during the AsCNP Congress Xi'an 2023.
Chair, Science Award Selection Committee
| Tadafumi Kato
|The Head of Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan
|The President of Zhejiang Chinese Medical University, and also the Prof of School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China
Chair, Lundbeck Science Award Committee
| Toshi A. Furukawa
|Professor and Chair of the Department of Health Promotion and Human Behavior, Professor of the Department of Clinical Epidemiology, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Japan.
He has published more than 400 Peer-reviewed original research articles and his major research interest is in the field of mood disorders.
|Head, The Molecular Psychiatry Laboratory, The Florey Institute for Neuroscience and Mental Health, Parkville, Australia.
Deputy Director, The Victorian Brain Bank Network, The Florey Institute for Neuroscience and Mental Health, Parkville, Australia.
Principal Research Fellow, Centre for Mental Health, Swinburne University of Technology, Hawthorn, Australia.
Professorial Fellow, University of Melbourne, Parkville, Australia.
He has published more than 250 Peer-reviewed original research articles and his major research interest is in the field of molecular abnormalities underpinning the pathophysiology of psychiatric disorders and new drug target of for treatment.